| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EDGE THERAPEUTICS INC | 1,933,582 | 22,169,000 | 18.21% | ||
| 2 | REGENXBIO INC COM | 1,030,954 | 15,874,000 | 13.04% | ||
| 3 | DBV Technologies | 230,167 | 14,146,000 | 11.62% | ||
| 4 | Ascendis Pharma | 721,152 | 13,212,000 | 10.85% | ||
| 5 | CYTOMX THERAPEUTICS INC COM | 603,031 | 11,642,000 | 9.56% | ||
| 6 | ALCOBRA LTD | 1,130,500 | 7,100,000 | 5.83% | ||
| 7 | COHERUS BIOSCIENCES INC COM | 259,259 | 5,953,000 | 4.89% | ||
| 8 | LIPOCINE INC NEW | 420,000 | 5,431,000 | 4.46% | ||
| 9 | AKARI THERAPEUTICS PLC | 369,490 | 5,358,000 | 4.40% | ||
| 10 | ARCA biopharma Inc | 1,078,932 | 5,017,000 | 4.12% | ||
| 11 | GLOBAL BLOOD THERAPEUTICS IN COM | 141,611 | 4,578,000 | 3.76% | ||
| 12 | Cynapsus Therapeutics Inc | 257,198 | 3,972,000 | 3.26% | ||
| 13 | AVALANCHE BIOTECHNOLOGIES IN | 280,000 | 2,666,000 | 2.19% | ||
| 14 | ProNAi Therapeutics, Inc. | 175,000 | 2,632,000 | 2.16% | ||
| 15 | STEMLINE THERAPEUTICS INC | 315,980 | 1,994,000 | 1.64% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-014521, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
